Clinical Trials Directory

Trials / Completed

CompletedNCT03931096

Quality of Life Assessment of Children With Congenital Heart Disease Aged 5 to 7 Years

Quality of Life Assessment of Children With Congenital Heart Disease Aged 5 to 7 Years : a Multicentre Controlled Cross-sectional Study

Status
Completed
Phase
Study type
Observational
Enrollment
248 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
5 Years – 7 Years
Healthy volunteers
Not accepted

Summary

Congenital heart diseases (CHD) are the firt cause of congenital malformations (8 for 1000 births). Since the 90's, great advances in prenatal diagnosis, pediatric cardiac surgery, intensive care, and cardiac catheterization have reduced morbidity and early mortality in this population. Prevalence of " GUCH ", grown-ups with congenital heart disease has thus been significantly increasing. Nowadays, quality of life (QoL) assessment of this population is in the foreground. Our team is a reference center in the management of patient with CHD, from the fetal period to adulthood. The investigators have been conducting a clinical research program on health related QoL in pediatric and congenital heart disease. The investigators thus demonstrated the link between cardiopulmonary fitness and QoL in children with CHD aged 8 to 18 years, the correlation between functional class and QoL in adults with CHD, and the impact of therapeutic education on QoL in children under anticoagulants. Currently, no controlled cross-sectional quality of life study assessment has been leaded in the youngest children with CHD. This present study therefore extends our work in younger children aged 5 to 7 years.

Detailed description

248 patients will be enrolled in this study. Patient from groups 1 is included during his annual medical check-up. Quality of life questionnaire and other examinations are performed during this site visit. Its is a part of his usual care. No supplementary visit, directly related to the research, are necessary. 2 sites will participate to the enrollment, belonging to the French national network for complex congenital heart diseases (M3C) . Participants (healthy children) from groups 2 are included from schools.The prior agreement of the Ministry of National Education was obtained before any procedure related to this study. 3 schools will participate to the enrolment

Conditions

Interventions

TypeNameDescription
OTHERQuality of life questionnaireSelf and proxy PedsQL 4.0 questionnaires.

Timeline

Start date
2019-02-01
Primary completion
2019-12-01
Completion
2019-12-31
First posted
2019-04-30
Last updated
2020-03-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03931096. Inclusion in this directory is not an endorsement.